` DCAL (Dishman Carbogen Amcis Ltd) vs BSE Sensex 30 Comparison - Alpha Spread

DCAL
vs
B
BSE Sensex 30

Over the past 12 months, DCAL has underperformed BSE Sensex 30, delivering a return of -15% compared to the BSE Sensex 30's +10% growth.

Stocks Performance
DCAL vs BSE Sensex 30

Loading
DCAL
BSE Sensex 30
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
DCAL vs BSE Sensex 30

Loading
DCAL
BSE Sensex 30
Difference
www.alphaspread.com

Performance By Year
DCAL vs BSE Sensex 30

Loading
DCAL
BSE Sensex 30
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Dishman Carbogen Amcis Ltd vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Dishman Carbogen Amcis Ltd
Glance View

Dishman Carbogen Amcis Ltd. is a manufacturing company, which engages in the provision of outsourcing services for the pharmaceutical industry. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2017-09-21. The firm's segments include CRAMS and Vitamin - D, Bulk Drugs, Quats, Specialty Chemicals and traded goods. The firm assists pharma companies through various stages of drug development from process research and development to late-stage clinical and commercial manufacturing facilities, along with the supply of active pharmaceutical ingredients (APIs) and intermediates. The firm has manufacturing and research facilities in India, Switzerland, France, Netherlands, United Kingdom and China. The firm's subsidiaries include CARBOGEN AMCIS (Shanghai) Co. Ltd, Dishman Infrastructure Ltd., Dishman Carbogen Amcis (Singapore) Pte. Ltd., CARBOGEN AMCIS Holding AG and Dishman Biotech Ltd.

DCAL Intrinsic Value
239.1 INR
Undervaluation 22%
Intrinsic Value
Price
Back to Top